Skip to Main Content

Paper Details

Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma.
Nat Commun
67
2019
6-AN, KEAP1, KRAS, KRAS oncoprotein, KRAS-mutant LUAD cancers, KRAS-mutant lung adenocarcinoma, KRAS-mutant lung cancer, Keap1, Keap1-deficient, KrasG12D, KrasG12D lung tumors, LUAD, NFE2L2, NRF2, bronchiolar cell, lung adenocarcinoma, pentose phosphate, pro-tumorigenic macrophages, tumor, tumors
Author NameAffiliation
Gavin M WrightSt Vincent's Hospital, The University of Melbourne
Matthew E RitchieThe Walter and Eliza Hall Institute of Medical Research
Matthew E RitchieThe University of Melbourne
Matthew E RitchieThe Walter and Eliza Hall Institute of Medical Research
Matthew E RitchieThe University of Melbourne
  • 1 - 5

Datasets

Release 1.2